Labcorp is a leading global life sciences company that provides vital insights to help doctors, hospitals, pharmaceutical companies, and researchers improve patient care. With a mission to improve health and lives, Labcorp delivers world-class diagnostic solutions and advances drug development through innovative technologies.
Labcorp is an Equal Opportunity Employer, committed to fostering an inclusive workplace free from discrimination. The company encourages applicants from diverse backgrounds, including individuals with disabilities and veterans.
Job Description
Labcorp is hiring an Informed Consent Codification Associate in Bangalore to support clinical trials by ensuring accurate and compliant codification of informed consent forms. This role is crucial in maintaining regulatory standards and improving clinical research processes.
Key Responsibilities:
✔ Perform informed consent codification across multiple client instances.
✔ Ensure codification is completed accurately and on schedule.
✔ Troubleshoot and resolve errors with strong analytical skills.
✔ Maintain knowledge of SOPs, validation procedures, and System Development Life Cycle (SDLC).
✔ Assist in metrics management and quality issue resolution.
✔ Suggest process improvements and support Six Sigma initiatives.
✔ Train and mentor colleagues on informed consent codification.
✔ Participate in special projects as assigned.
Qualifications & Skills Required:
✅ University/College degree (preferably in sciences or related field).
✅ 0-1 year of experience in clinical trials, laboratory, or specimen management.
✅ Knowledge of informed consent forms (ICF) and global regulations.
✅ Strong MS Office (Excel, Word) skills.
✅ Excellent communication, problem-solving, and attention to detail.
Why Join Labcorp?
🔹 Work with a global leader in life sciences and clinical research.
🔹 Inclusive and diverse work environment.
🔹 Opportunities for career growth and skill development.
🔹 Contribute to life-changing medical research and innovations.
How to Apply?
📅 Last Date: June 16, 2025
